#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...